Mercer Global Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Buy |
58,826
+16,469
| +39% | +$875K | 0.01% | 693 |
|
|
2025
Q1 | $1.83M | Buy |
42,357
+2,869
| +7% | +$124K | ﹤0.01% | 862 |
|
|
2024
Q4 | $2.22M | Buy |
39,488
+1,589
| +4% | +$89.3K | 0.01% | 790 |
|
|
2024
Q3 | $2.58M | Buy |
37,899
+5,818
| +18% | +$396K | 0.01% | 690 |
|
|
2024
Q2 | $1.36M | Buy |
32,081
+3,674
| +13% | +$156K | ﹤0.01% | 841 |
|
|
2024
Q1 | $1.96M | Buy |
28,407
+2,409
| +9% | +$166K | 0.01% | 729 |
|
|
2023
Q4 | $1.92M | Sell |
25,998
-8
| -0% | -$592 | 0.01% | 754 |
|
|
2023
Q3 | $1.77M | Buy |
26,006
+19,654
| +309% | +$1.34M | 0.01% | 748 |
|
|
2023
Q2 | $596K | Buy |
+6,352
| New | +$596K | ﹤0.01% | 1151 |
|
|
2020
Q2 | – | Sell |
-3,676
| Closed | -$213K | – | 1054 |
|
|
2020
Q1 | $213K | Sell |
3,676
-102
| -3% | -$5.91K | ﹤0.01% | 919 |
|
|
2019
Q4 | $349K | Buy |
+3,778
| New | +$349K | 0.01% | 863 |
|